1-6 of 6
Shahnaz Shahinfar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy

Steef J. Sinkeler, MD, Arjan J. Kwakernaak, MD, Stephan J.L. Bakker, MD, Shahnaz Shahinfar, MD, Enric Esmatjes, MD, Dick de Zeeuw, MD, Gerjan Navis, MD, Hiddo J. Lambers Heerspink, PHARMD
Journal: Diabetes Care
Diabetes Care 2013;36(6):1489–1494
https://doi.org/10.2337/dc12-1545
Published: 15 May 2013
View article titled, Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy
Open the PDF for Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy in another window
Includes: Supplementary data
Journal Articles

Effect of LDL Cholesterol and Treatment With Losartan on End-Stage Renal Disease in the RENAAL Study

Andrew M. Tershakovec, MD, William F. Keane, MD, Zhongxin Zhang, PHD, Paulette A. Lyle, BS, Gerald B. Appel, MD, Janet B. McGill, MD, Hans-Henrik Parving, MD, Mark E. Cooper, MD, PHD, Shahnaz Shahinfar, MD, Barry M. Brenner, MD
Journal: Diabetes Care
Diabetes Care 2008;31(3):445–447
https://doi.org/10.2337/dc07-0196
Published: 01 March 2008
View article titled, Effect of LDL Cholesterol and Treatment With Losartan on End-Stage Renal Disease in the RENAAL Study
Open the PDF for Effect of LDL Cholesterol and Treatment With Losartan on End-Stage Renal Disease in the RENAAL Study in another window
Journal Articles

Efficacy and Safety of Angiotensin II Receptor Blockade in Elderly Patients With Diabetes

Wolfgang C. Winkelmayer, MD, SCD, Zhongxin Zhang, PHD, Shahnaz Shahinfar, MD, Mark E. Cooper, MD, PHD, Jerry Avorn, MD, Barry M. Brenner, MD
Journal: Diabetes Care
Diabetes Care 2006;29(10):2210–2217
https://doi.org/10.2337/dc06-0570
Published: 01 October 2006
View article titled, Efficacy and Safety of Angiotensin II Receptor Blockade in Elderly Patients With Diabetes
Open the PDF for Efficacy and Safety of Angiotensin II Receptor Blockade in Elderly Patients With Diabetes in another window
Journal Articles

Renin Angiotensin Aldosterone System Blockade and Renal Disease in Patients With Type 2 Diabetes: An Asian perspective from the RENAAL study

Juliana C.N. Chan, MD, FRCP, Nelson M.S. Wat, MBBS, MRCP, Wing-Yee So, MBBS, MRCP, Karen S.L. Lam, MD, FRCP, Chin-Teong Chua, MRCP, FRCP, Kok-Seng Wong, MMED, MRCP, FAMS, Zaki Morad, MRCP, FRCP, Tania Z. Dickson, PHD, Darcy Hille, EMBA, Zhongxin Zhang, PHD, Mark E. Cooper, MBBS, MD, PHD, FRACP, Shahnaz Shahinfar, MD, Barry M. Brenner, MD, Kiyoshi Kurokawa, MD, on behalf of the Asian RENAAL Study Investigators
Journal: Diabetes Care
Diabetes Care 2004;27(4):874–879
https://doi.org/10.2337/diacare.27.4.874
Published: 01 April 2004
View article titled, Renin Angiotensin Aldosterone System Blockade and Renal Disease in Patients With Type 2 Diabetes: <subtitle>An Asian perspective from the RENAAL study </subtitle>
Open the PDF for Renin Angiotensin Aldosterone System Blockade and Renal Disease in Patients With Type 2 Diabetes: <subtitle>An Asian perspective from the RENAAL study </subtitle> in another window
Journal Articles

Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study

Gerald B. Appel, MD, Jai Radhakrishnan, MD, Morrell M. Avram, MD, Ralph A. DeFronzo, MD, Fernando Escobar-Jimenez, MD, M.M. Campos, MD, Ellen Burgess, MD, Darcy A. Hille, MS, EMBA, Tania Z. Dickson, PHD, Shahnaz Shahinfar, MD, Barry M. Brenner, MD, for the RENAAL Study Investigators
Journal: Diabetes Care
Diabetes Care 2003;26(5):1402–1407
https://doi.org/10.2337/diacare.26.5.1402
Published: 01 May 2003
View article titled, Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study
Open the PDF for Analysis of Metabolic Parameters as Predictors of Risk in the RENAAL Study in another window
Journal Articles

Losartan Reduces the Costs Associated With Diabetic End-Stage Renal Disease: The RENAAL study economic evaluation

William H. Herman, MD, MPH, Shahnaz Shahinfar, MD, George W. Carides, PHD, Erik J. Dasbach, PHD, William C. Gerth, MBA, Charles M. Alexander, MD, John R. Cook, PHD, William F. Keane, MD, Barry M. Brenner, MD, For the RENAAL Investigators
Journal: Diabetes Care
Diabetes Care 2003;26(3):683–687
https://doi.org/10.2337/diacare.26.3.683
Published: 01 March 2003
View article titled, Losartan Reduces the Costs Associated With Diabetic End-Stage Renal Disease: <subtitle>The RENAAL study economic evaluation</subtitle>
Open the PDF for Losartan Reduces the Costs Associated With Diabetic End-Stage Renal Disease: <subtitle>The RENAAL study economic evaluation</subtitle> in another window